Eliquis and Xarelto, two blood-thinning medications that are already among Medicare's costliest, have seen their list prices more than double since entering the market, finds a new report by Patients ...

Johnson & Johnson and Bayer’s Xarelto, once king of the warfarin alternative market, is now chasing chasing Pfizer and Bristol-Myers Squibb's Eliquis. But with a new approved indication in the ...

(Reuters) -Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to ...

CMS released its highly anticipated list of 10 drugs subject to Medicare price negotiations Tuesday, which includes popular blood clot prevention drugs Eliquis and Xarelto and diabetes drugs Jardiance ...

Medicare’s 2026 drug price negotiations under the Inflation Reduction Act aim to lower the cost of expensive medications, ...

With Bristol-Myers Squibb (BMY) and Pfizer (PFE) throwing everything they’ve got behind Eliquis, Bayer (OTCPK:BAYRY) and Johnson & Johnson (JNJ) need to keep up the pressure with Xarelto. These ...

Choice of direct oral anticoagulant (DOAC) mattered for clinical outcomes among adults with atrial fibrillation (Afib), a study based on U.S. insurance claims found. Apixaban (Eliquis) users had ...

Q: I was taking Coumadin for my heart and then I saw commercials for Eliquis and Xarelto. I was thinking to ask my doctor about switching because then I do not have to do lab work so much. What is the ...

Combined Sales of The NOACs Above Grew From $3.9 Billion In 2014 To $11.8 Billion In 2018. Eliquis’ Share Increased From 20% To 54% During The Same Period, As The Drug Saw Stellar Growth In The Recent ...

The first 10 prescription drugs the federal government will negotiate under a new federal law were revealed Tuesday, launching a process that could deliver drug discounts by 2026. The batch of 10 ...

With an approval filing already on the FDA’s docket, Bayer and Johnson & Johnson are padding their case for launching legacy blood thinner Xarelto in artery disease patients after surgery. In ...

Older adults taking Bayer AG's blockbuster blood thinner pill Xarelto for a common type of irregular heart rhythm had significantly higher rates of serious bleeding and stroke compared to those taking ...